- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x CA: CALCIUM ION(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 13 x IOD: IODIDE ION(Non-functional Binders)
IOD.5: 4 residues within 4Å:- Chain A: G.194, N.195, S.196, R.356
Ligand excluded by PLIPIOD.6: 3 residues within 4Å:- Chain A: S.601, A.746, D.747
Ligand excluded by PLIPIOD.7: 2 residues within 4Å:- Chain A: L.529, C.531
Ligand excluded by PLIPIOD.8: 3 residues within 4Å:- Chain A: H.246, S.272, T.299
Ligand excluded by PLIPIOD.9: 2 residues within 4Å:- Chain A: M.197, Y.198
Ligand excluded by PLIPIOD.10: 2 residues within 4Å:- Chain A: L.753, R.808
Ligand excluded by PLIPIOD.11: 1 residues within 4Å:- Chain A: P.128
Ligand excluded by PLIPIOD.12: 1 residues within 4Å:- Chain A: C.50
Ligand excluded by PLIPIOD.13: 3 residues within 4Å:- Chain A: R.711, T.713, E.714
Ligand excluded by PLIPIOD.14: 1 residues within 4Å:- Chain A: S.811
Ligand excluded by PLIPIOD.15: 3 residues within 4Å:- Chain A: G.352, H.417, V.418
Ligand excluded by PLIPIOD.16: 2 residues within 4Å:- Chain A: N.363, N.364
Ligand excluded by PLIPIOD.35: 2 residues within 4Å:- Chain A: K.464, P.466
Ligand excluded by PLIP- 1 x 7CW: [3,5-bis(chloranyl)phenyl]methyl ~{N}-[2-[[(4~{R})-4-[(3~{R},5~{S},7~{S},8~{R},9~{S},10~{S},13~{R},14~{S},17~{R})-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethyl]carbamate(Non-covalent)
7CW.17: 16 residues within 4Å:- Chain A: L.43, Y.47, I.132, S.134, F.175, L.178, A.182, K.213, F.214, H.216, W.219, W.225, F.238, F.239, W.240, Y.271
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:F.175, A:L.178, A:K.213, A:F.214, A:F.214, A:W.219, A:W.219, A:F.239, A:F.239
- Hydrogen bonds: A:W.225, A:W.240, A:W.240
- 1 x NA: SODIUM ION(Non-functional Binders)
- 11 x SCN: THIOCYANATE ION(Non-functional Binders)
SCN.19: 3 residues within 4Å:- Chain A: S.641, P.671, K.674
No protein-ligand interaction detected (PLIP)SCN.20: 3 residues within 4Å:- Chain A: K.460, Y.461, R.500
No protein-ligand interaction detected (PLIP)SCN.21: 4 residues within 4Å:- Chain A: S.141, Y.142, K.145, F.285
No protein-ligand interaction detected (PLIP)SCN.22: 3 residues within 4Å:- Chain A: T.572, S.573, I.589
No protein-ligand interaction detected (PLIP)SCN.23: 3 residues within 4Å:- Chain A: T.229, G.232, R.234
No protein-ligand interaction detected (PLIP)SCN.24: 5 residues within 4Å:- Chain A: F.125, V.126, D.261, R.264, S.266
1 PLIP interactions:1 interactions with chain A- Water bridges: A:R.127
SCN.25: 5 residues within 4Å:- Chain A: L.349, P.351, A.419, R.420, D.424
No protein-ligand interaction detected (PLIP)SCN.26: 5 residues within 4Å:- Chain A: N.475, P.487, N.488, G.490, H.492
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.475, A:N.488, A:H.492
SCN.27: 3 residues within 4Å:- Chain A: L.341, T.342, T.371
No protein-ligand interaction detected (PLIP)SCN.28: 6 residues within 4Å:- Chain A: F.468, E.472, S.494, L.495, T.815, T.818
No protein-ligand interaction detected (PLIP)SCN.29: 3 residues within 4Å:- Chain A: S.754, V.755, Y.819
No protein-ligand interaction detected (PLIP)- 5 x GOL: GLYCEROL(Non-functional Binders)
GOL.30: 1 residues within 4Å:- Chain A: V.75
No protein-ligand interaction detected (PLIP)GOL.31: 6 residues within 4Å:- Chain A: Q.391, H.392, D.704, Y.707, T.730, H.731
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:H.392, A:D.704, A:R.763
GOL.32: 4 residues within 4Å:- Chain A: T.507, P.509, R.792, Y.810
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.792, A:Y.810
GOL.33: 7 residues within 4Å:- Chain A: Y.570, F.590, L.594, P.701, F.703, R.711, T.798
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Y.570, A:P.701, A:R.711
- Water bridges: A:D.712
GOL.34: 2 residues within 4Å:- Chain A: D.765, D.767
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Keune, W.J. et al., Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators. J. Med. Chem. (2017)
- Release Date
- 2017-08-16
- Peptides
- Ectonucleotide pyrophosphatase/phosphodiesterase family member 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x CA: CALCIUM ION(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 13 x IOD: IODIDE ION(Non-functional Binders)
- 1 x 7CW: [3,5-bis(chloranyl)phenyl]methyl ~{N}-[2-[[(4~{R})-4-[(3~{R},5~{S},7~{S},8~{R},9~{S},10~{S},13~{R},14~{S},17~{R})-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethyl]carbamate(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 11 x SCN: THIOCYANATE ION(Non-functional Binders)
- 5 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Keune, W.J. et al., Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators. J. Med. Chem. (2017)
- Release Date
- 2017-08-16
- Peptides
- Ectonucleotide pyrophosphatase/phosphodiesterase family member 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A